Cargando…
Molecular Signatures of Recurrent Hepatocellular Carcinoma Secondary to Hepatitis C Virus following Liver Transplantation
Chronic hepatitis C virus (HCV) induced hepatocellular carcinoma (HCC) is a primary indication for liver transplantation (LT). In western countries, the estimated rate of HCC recurrence following LT is between 15% and 20% and is a major cause of mortality. Currently, there is no standard method to t...
Autores principales: | Das, Trina, Diamond, Deborah L., Yeh, Matthew, Hassan, Sajida, Bryan, Janine T., Reyes, Jorge D., Perkins, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860124/ https://www.ncbi.nlm.nih.gov/pubmed/24377043 http://dx.doi.org/10.1155/2013/878297 |
Ejemplares similares
-
Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure
por: Lee, I-Cheng, et al.
Publicado: (2017) -
Hepatic Artery Chemoembolization for Hepatocellular Carcinoma Recurrence Confined to the Transplanted Liver
por: Carr, Brian I.
Publicado: (2012) -
HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers
por: Ijaz, Bushra, et al.
Publicado: (2019) -
Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021) -
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
por: Duda, Dan G., et al.
Publicado: (2020)